Thursday, February 18, 2016  |  Volume 8 / Number 4  |  A Production of the BioProcessing Journal
ISBioTech 6th Spring Meeting
Career Development
7th Annual Virginia Regional Herpes Symposium
March 19, 2016
Norfolk, Virginia USA
5th International
Symposium on HOS
April 11–13, 2016
Long Beach, California USA
CMC Strategy Forum
Europe 2016
May 9–11, 2016
Paris, France
19th Annual Meeting
May 4–7, 2016
Washington, DC USA
Host Cell Protein Workshop
May 17–19, 2016
Lisbon, Portugal
29th International Symposium
July 17–20, 2016
Philadelphia, PA USA
HPLC 2016
44th International Symposium
June 19–24, 2016
San Francisco, CA USA
Suggested Reading
Development of a Novel Flow Cytometry-Based Titration Assay
to Quantify Herpes Simplex Virus Type 1 (HSV-1)
By Brittany P. Lassiter and Neel K. Krishna, PhD, Eastern Virginia Medical School (EVMS), et al.
Sponsored Link
Pall Life Sciences Pall Life Sciences Pall Life Sciences
Pall Life Sciences is pleased to announce an agreement with Kaneka Corporation to supply its KANEKA KanCapA™ Protein A chromatography sorbent.

This unique sorbent features a high-dynamic binding capacity for the primary capture of monoclonal antibodies and related biomolecules from clarified cell culture supernatant.

The addition of the KANEKA KanCapA sorbent complements Pall's continuous chromatography portfolio, which features innovative technologies that make each step of the process more efficient than ever. KANEKA KanCapA is available in a range of pre-packed columns, and in bulk for use with the Resolute® AutoPak system.

Pall Life Sciences
Products & Services
Pioneering Regenerative Medicine Efforts with Scaffold-Free, 3D Tissue Bioprinter
The LifeNet Health Institute of Regenerative Medicine (IRM) has installed a robotic "bioprinter" at its primary research and development facility in Virginia Beach, Virginia. The Regenova® 3D Bio Printer, a system developed by Japan-based Cyfuse Biomedical K.K., allows three-dimensional tissues to be fabricated from specific kinds of cells.
LifeNet Health's Regenova system will be the first of its kind operating on the East Coast. Regenova does not rely on additional scaffolds such as collagen to support tissue structures. The system's unique mechanism allows the cells alone to form shapes such as spheres, tubes, rods or sheets.

LifeNet Health recently launched its Life Sciences Cell Products division, which prepares human primary cells and an array of other products for the medical research market, and will be developing resources that leverage the bioprinter's capabilities. For more information, please visit
Regenova® 3D Bio Printer
3D Microtissue-Based Assay Chapter in NCATS/NIH Assay Guidance Manual
InSphero AG has contributed a chapter in the NIH National Center for Advancing Translational Sciences (NCATS) Assay Guidance Manual, which describes best practices for adapting and standardizing high-throughput assays for use with 3D microtissues. The chapter, “In vitro 3D Spheroids and Microtissues: ATP-based Cell Viability and Toxicity Assays,” was co-authored by Dr. Monika Kijanska and Dr. Jens M. Kelm of InSphero, and appears in a 2016 update to the eBook published last week.
CAS-MAP™ The chapter addresses considerations for choosing an appropriate 3D model, provides guidance on selection of reagents and protocol adaptations proven to work in a 3D setting, and gives specific examples of cell viability and toxicity assay results obtained with InSphero 3D InSight™ Human Liver Microtissues and Tumor Microtissues.

The manual's content is currently edited by 19 researchers representing 11 institutions, including NCATS and Eli Lilly & Co.

For more information, please visit
Career Development
Emerging Targeted Therapies in Cancer and Autoimmunity
April 21–25, 2016
Varadero, Cuba
7th Monolith Summer School and Symposium
May 27–June 1, 2016
Portorož, Slovenia
BPJ Publishing
BioProcessing Journal BioProcessing Journal BioProcessing Journal
Economize by combining Techno-Blast and BioProcessing Journal advertising into one package.

Request a media kit today!
Techno-Blast Masthead
An artist’s illustration of eukaryotic cells transforming abnormally.
Did a colleague forward this to you? Subscribe here. While we'd hate to see you go, you can unsubscribe instantly.